Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Lusutrombopag

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3VANCOCIN ITALIA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    ELCC
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    ELCC
    Not Confirmed

    Patent Expiration Date : 2031-09-29

    LUSUTROMBOPAG

    US Patent Number : 9427402

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2031-09-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    ELCC
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    ELCC
    Not Confirmed

    Patent Expiration Date : 2028-07-29

    LUSUTROMBOPAG

    US Patent Number : 8889722

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-07-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    ELCC
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    ELCC
    Not Confirmed

    Patent Expiration Date : 2030-01-21

    LUSUTROMBOPAG

    US Patent Number : 8530668

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2030-01-21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF